Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Welcome to the Tessa News Link Beta! We are actively improving this experience.

Share Feedback

Source study found

Story checked

Occasional male cannabis users experience stronger effects than women (opens in a new tab)

news-medical.net · 2026-11-06

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One claim goes further than the study. 5 other points were not covered by the paper.

  • 1 supported
  • 1 overstated
  • 5 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Notice: Analysis is currently derived from study abstracts. Full-text paper analysis capabilities are currently in development.

Share this check

Help improve NewsLink

Tell us what worked or what needs attention in this check.

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

One claim overstates the study. One of seven checks out. Five claims the study doesn't address.

  • 1 supported
  • 1 overstated
  • 5 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Claim 1 of 7OverstatedWomen and men who used cannabis frequently responded to it in similar ways, and frequent users exhibited more addictive qualities of cannabis than occasional users regardless of sex.View evidenceHide evidence

Why this verdict

The profile supports that frequent users had higher misuse-related ratings such as 'Like' and 'Take again' and self-administered more cannabis than occasional users, with those effects reported as not modified by sex. But the broader claim that frequent-use women and men responded in similar ways overall outruns the abstract evidence, which does not establish global similarity across all subjective, PK, and behavioral responses and notes a PK trend toward highest THC/metabolite concentrations in frequent-use males.

1

Study evidence

Active cannabis strengths (4% and 10% THC) increased subjective effects relative to placebo.ps < 0.05

“...completed subjective mood and drug effects assessments”
2

Study evidence

Frequent-use participants (>4 days/week) self-administered more cannabis than occasional-use participants in a post-smoking self-administration task; this difference emerged in an exploratory follow-up of a cannabis strength-by-frequency interaction and was not modified by sex.p < 0.05 for group difference (no effect magnitude reported); interaction p < 0.10

“...and a self-administration task.”
Claim 2 of 7Not coveredMen who use cannabis occasionally reacted more strongly to smoked cannabis than women with similar use habits, even though the amount of THC in their blood was about the same.View evidenceHide evidence

Why this verdict

The abstract-profile supports that occasional-use males had higher active-dose ratings for 'High,' sedation/impairment, dysphoric arousal, and 'Bad effect' than sex- and/or frequency-matched counterparts. However, the claim’s headline-level assertion that this occurred despite about-the-same blood THC is not established in the abstract profile; PK details by occasional-use male versus comparable women are not provided, and the profile instead notes only a trend toward highest THC/metabolite concentrations in frequent-use males.

1

Study evidence

Active (4% and 10%) smoked cannabis increased plasma THC and metabolite concentrations relative to placebo.

“In this randomized, double-blind, placebo-controlled crossover study, 44 participants (22 F) smoked three cannabis strengths (0% [~0 mg] THC, 4% [~20 mg] THC, 10% [~60 mg] THC), provided blood for plasma analysis”
2

Study evidence

Active cannabis strengths (4% and 10% THC) increased subjective effects relative to placebo.ps < 0.05

“...completed subjective mood and drug effects assessments”
Claim 3 of 7Not coveredThe study was published in Neuropsychopharmacology and is described as the first experiment designed to test how sex and frequency of use together shape the short-term effects of smoked cannabis.View evidenceHide evidence

Why this verdict

The abstract-profile supports that the study tested acute effects of smoked cannabis as a function of sex and use frequency in a randomized crossover experiment. But it does not verify publication venue or the stronger novelty claim that this was the first experiment designed to test sex and frequency together.

1

Study evidence

Active (4% and 10%) smoked cannabis increased plasma THC and metabolite concentrations relative to placebo.

“In this randomized, double-blind, placebo-controlled crossover study, 44 participants (22 F) smoked three cannabis strengths (0% [~0 mg] THC, 4% [~20 mg] THC, 10% [~60 mg] THC), provided blood for plasma analysis”
2

Study evidence

Active cannabis strengths (4% and 10% THC) increased subjective effects relative to placebo.ps < 0.05

“...completed subjective mood and drug effects assessments”
Claim 4 of 7Not coveredResearchers at UCLA Center for Cannabis and Cannabinoids enrolled healthy adults split evenly by sex and by how often they used cannabis, with participants in three sessions smoking placebo, lower-THC, and higher-THC cannabis.View evidenceHide evidence

Why this verdict

The core dosing design is supported: N=44, 22 female, randomized double-blind placebo-controlled crossover sessions with 0%, 4%, and 10% THC, and analyses by sex and use frequency. However, the abstract-profile does not verify UCLA Center affiliation, that participants were healthy adults, or that the sample was split evenly by use-frequency group rather than balanced across sex.

1

Study evidence

Active (4% and 10%) smoked cannabis increased plasma THC and metabolite concentrations relative to placebo.

“In this randomized, double-blind, placebo-controlled crossover study, 44 participants (22 F) smoked three cannabis strengths (0% [~0 mg] THC, 4% [~20 mg] THC, 10% [~60 mg] THC), provided blood for plasma analysis”
2

Study evidence

Active cannabis strengths (4% and 10% THC) increased subjective effects relative to placebo.ps < 0.05

“...completed subjective mood and drug effects assessments”
Claim 5 of 7Not coveredMen who used cannabis occasionally reported feeling more high, sedated and impaired than other participants, along with more unpleasant effects such as anxiety, and they were the only group whose heart rate rose significantly after smoking active cannabis.View evidenceHide evidence

Why this verdict

The abstract-profile supports higher active-dose ratings among occasional-use males for 'High,' sedation/impairment, dysphoric arousal, and 'Bad effect' in exploratory follow-up. But the story adds anxiety specifically and a significant heart-rate increase unique to that group; those details are not in the supplied abstract-profile. The phrase 'than other participants' is also broader than the profile’s 'sex- and/or frequency-matched counterparts' wording.

1

Study evidence

Active cannabis strengths (4% and 10% THC) increased subjective effects relative to placebo.ps < 0.05

“...completed subjective mood and drug effects assessments”
Claim 6 of 7Not coveredThe sample was modest, several findings were exploratory, and the THC strengths tested were lower than those of many products sold today.View evidenceHide evidence

Why this verdict

The profile supports the caveats that the sample was modest and that several subgroup/interaction findings were exploratory. However, the supplied abstract-profile does not state that the THC strengths tested were lower than those of many current commercial products, so that part is not verifiable at this evidence depth.

1

Study evidence

Active (4% and 10%) smoked cannabis increased plasma THC and metabolite concentrations relative to placebo.

“In this randomized, double-blind, placebo-controlled crossover study, 44 participants (22 F) smoked three cannabis strengths (0% [~0 mg] THC, 4% [~20 mg] THC, 10% [~60 mg] THC), provided blood for plasma analysis”
2

Study evidence

Active cannabis strengths (4% and 10% THC) increased subjective effects relative to placebo.ps < 0.05

“...completed subjective mood and drug effects assessments”
Claim 7 of 7SupportedThe findings run counter to earlier research suggesting that women are more sensitive to cannabis.View evidenceHide evidence

Why this verdict

The profile states that prior studies suggested females may be more sensitive to THC/cannabis effects and that the authors discuss their findings as contrasting with that prior evidence. The story’s framing that the findings run counter to earlier research is supported at abstract depth.

1

Study evidence

Active (4% and 10%) smoked cannabis increased plasma THC and metabolite concentrations relative to placebo.

“In this randomized, double-blind, placebo-controlled crossover study, 44 participants (22 F) smoked three cannabis strengths (0% [~0 mg] THC, 4% [~20 mg] THC, 10% [~60 mg] THC), provided blood for plasma analysis”
2

Study evidence

Active cannabis strengths (4% and 10% THC) increased subjective effects relative to placebo.ps < 0.05

“...completed subjective mood and drug effects assessments”
Then look for missing context

Context layer

What the story carried across

Nothing material from the study was dropped.

4 things the story did carry across
  • Randomized, double-blind, placebo-controlled crossover human study with 44 participants, 22 female, smoking 0%, 4%, and 10% THC cannabis, with analyses by sex and use frequency.
  • Subjective pharmacodynamic finding: occasional-use males had higher active-dose ratings for 'High,' sedation/impairment, dysphoric arousal, and 'Bad effect' in exploratory follow-up comparisons.
  • Frequent users showed increased misuse-related ratings ('Like,' 'Take again') and greater cannabis self-administration than occasional users, and these effects were reported as not modified by sex.
  • Important inferential limitations: several sex/frequency subgroup and interaction findings were exploratory, some using a p < 0.10 interaction-follow-up threshold; the sample was modest for subgroup analyses.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoTest acute pharmacokinetic (plasma THC and metabolites) effects of smoked cannabis as a function of THC strength, sex, and cannabis use frequency in a randomized, double-blind, placebo-controlled crossover human study.randomized double-blind placebo-controlled crossoverExpand

In plain English

Randomized, double-blind, placebo-controlled crossover study (N=44, 22 female) assessing acute plasma THC and metabolite concentrations after smoked cannabis at 0%, 4%, and 10% THC, with analyses stratified by sex and self-reported cannabis use frequency (>4 vs ≤4 days/week). Active cannabis increased plasma THC and metabolites versus placebo; exploratory analyses indicated trends toward higher THC/metabolite concentrations in frequent-use males.

Key findings

  • Active (4% and 10%) smoked cannabis increased plasma THC and metabolite concentrations relative to placebo.
  • THC and metabolite concentrations tended to be highest in frequent-use males.
“In this randomized, double-blind, placebo-controlled crossover study, 44 participants (22 F) smoked three cannabis strengths (0% [~0 mg] THC, 4% [~20 mg] THC, 10% [~60 mg] THC), provided blood for plasma analysis”
What this piece can’t prove
  • Abstract does not report numeric PK parameters (e.g., Cmax, Tmax, AUC) or effect size estimates for plasma THC/metabolites.
  • Some subgroup/interaction analyses were described as exploratory (strength × frequency follow-up reported with p < 0.10), limiting inferential certainty.
  • Moderate overall sample size (N=44) with subgroup splits (sex, frequency) may limit power for detecting sex × frequency interactions in PK outcomes.
  • The abstract reports a tendency for higher exposure in frequent-use males but does not provide statistical details to confirm significance.
2human in vivoTest acute pharmacodynamic/subjective effects (mood and drug effects ratings, including misuse-related ratings) of smoked cannabis across THC strengths, sex, and use frequency in the same crossover trial.Randomized double-blind placebo-controlled crossover dosingExpand

In plain English

In a randomized, double-blind, placebo-controlled crossover trial (N=44, 22 female), participants smoked cannabis at 0%, 4%, and 10% THC and completed standardized subjective mood and drug-effect ratings plus a self-administration task. Active cannabis increased subjective effects versus placebo; exploratory interaction follow-up by use-frequency (frequent >4 days/week vs occasional ≤4 days/week) indicated frequent users showed increased misuse-related ratings and greater self-administration, whereas occasional-use males reported larger increases in 'High', sedation/impairment, dysphoric arousal, and 'Bad effect' at active strengths. Analyses examined effects by cannabis strength, sex, and frequency, with some inferential follow-up of interaction signals (cannabis strength*frequency p < 0.10).

Key findings

  • Active cannabis strengths (4% and 10% THC) increased subjective effects relative to placebo.ps < 0.05
  • Frequent users (>4 days/week) showed significant increases from placebo in misuse-related ratings ('Like', 'Take again') and self-administered more cannabis than occasional users in exploratory follow-up.interaction follow-up: cannabis strength*frequency p < 0.10; misuse-related ratings and self-administration ps < 0.05
“...completed subjective mood and drug effects assessments”
What this piece can’t prove
  • Analyses of interactions and some subgroup comparisons were exploratory (interaction follow-up used a p < 0.10 threshold); abstract lacks full statistical detail (models, corrections for multiple comparisons).
  • Sample size is N=44 (22 female); subgroup/exploratory findings may have limited precision (noted in abstract context but detailed power analyses not provided).

1 further detail could not be confirmed from the summary.

3human in vivoAssess acute cannabis reinforcement/misuse behavior via a post-smoking self-administration task and how it varies by THC strength, sex, and use frequency.randomized double-blind placebo-controlled crossover dosingExpand

In plain English

In a randomized, double-blind, placebo-controlled crossover study of 44 participants (22 female) who smoked placebo (0% THC), 4% THC, and 10% THC, frequent users (>4 days/week) self-administered more cannabis than occasional users in a post-smoking self-administration task; this difference was reported in an exploratory follow-up of a cannabis strength-by-frequency interaction and was not modified by sex (ps < 0.05; interaction p < 0.10).

Key findings

  • Frequent-use participants (>4 days/week) self-administered more cannabis than occasional-use participants in a post-smoking self-administration task; this difference emerged in an exploratory follow-up of a cannabis strength-by-frequency interaction and was not modified by sex.p < 0.05 for group difference (no effect magnitude reported); interaction p < 0.10
“...and a self-administration task.”
What this piece can’t prove
  • Self-administration finding was identified via exploratory follow-up of an interaction (interaction p < 0.10), so it may be hypothesis-generating rather than confirmatory.
  • Modest overall sample size (N=44) limits power for subgroup analyses by sex and frequency.

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Sex- and frequency-dependent acute pharmacokinetic and pharmacodynamic effects of smoked cannabis: a randomized controlled trial.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026

Deep dive in Tessa (opens in a new tab)Source record (opens in a new tab)

Why this one

Confident

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 15 candidate papers

Selected

Sex- and frequency-dependent acute pharmacokinetic and pharmacodynamic effects of smoked cannabis: a randomized controlled trial.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology · 2026 · PubMed

Tessa (opens in a new tab)Source (opens in a new tab)
Candidate

Acute Effects of Cigarette Smoking on Blood Pressure and Heart Rate in University Students

Journal of Cardiovascular Nursing · 2025 · Crossref

Source (opens in a new tab)
Candidate

The effects of cigarette smoking on metabolic rate, heart rate, oxygen pulse, and breathing rate

American Heart Journal · 1940 · Crossref

Source (opens in a new tab)

And 9 more candidates considered.